Viewing Study NCT05801835


Ignite Creation Date: 2025-12-24 @ 10:14 PM
Ignite Modification Date: 2026-03-27 @ 1:09 PM
Study NCT ID: NCT05801835
Status: RECRUITING
Last Update Posted: 2023-09-21
First Post: 2023-03-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for Injection
Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module